A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicity. (Q54003338)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicity. |
scientific article |
Statements
A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicity (English)
B J Smit
C F Albrecht
R W Liebenberg
P B Kruger
M Freestone
L Gouws
E Theron
P J Bouic
S Etsebeth
P P van Jaarsveld
1 September 1995